Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :15102711
Publication Date : //

Laforin preferentially binds the neurotoxic starch-like polyglucosans, which form in its absence in progressive myoclonus epilepsy.


Lafora disease (LD) is a fatal and the most common form of adolescent-onset progressive epilepsy. Fulminant endoplasmic reticulum (ER)-associated depositions of starch-like long-stranded, poorly branched glycogen molecules [known as polyglucosans, which accumulate to form Lafora bodies (LBs)] are seen in neuronal perikarya and dendrites, liver, skeletal muscle and heart. The disease is caused by loss of function of the laforin dual-specificity phosphatase or the malin E3 ubiquitin ligase. Towards understanding the pathogenesis of polyglucosans in LD, we generated a transgenic mouse overexpressing inactivated laforin to trap normal laforin's unknown substrate. The trap was successful and LBs formed in liver, muscle, neuronal perikarya and dendrites. Using immunogold electron microscopy, we show that laforin is found in close proximity to the ER surrounding the polyglucosan accumulations. In neurons, it compartmentalizes to perikaryon and dendrites and not to axons. Importantly, it binds polyglucosans, establishing for the first time a direct association between the disease-defining storage product and disease protein. It preferentially binds polyglucosans over glycogen in vivo and starch over glycogen in vitro, suggesting that laforin's role begins after the appearance of polyglucosans and that the laforin pathway is involved in monitoring for and then preventing the formation of polyglucosans. In addition, we show that the laforin interacting protein, EPM2AIP1, also localizes on the polyglucosan masses, and we confirm laforin's intense binding to LBs in human LD biopsy material.

Authors : Chan Elayne M , Ackerley Cameron A , Lohi Hannes , Ianzano Leonarda , Cortez Miguel A , Shannon Patrick , Scherer Stephen W , Minassian Berge A ,

Related products :

Catalog number Product name Quantity
EPN1 EPM2A Gene epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
60229 IgG,epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) (EPM2A), transcript variant 1 0.1 mg
GWB-835A73 epilepsy progressive myoclonus type 2A Lafora disease (laforin) (EPM2A) transcript variant 1, Antibody
CSB-EL007738DO Dog epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) (EPM2A) ELISA kit, Species Dog, Sample Type serum, plasma 96T
CSB-EL007738RA Rat epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) (EPM2A) ELISA kit, Species Rat, Sample Type serum, plasma 96T
CSB-EL007738MO Mouse epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) (EPM2A) ELISA kit, Species Mouse, Sample Type serum, plasma 96T
CSB-EL007738HU Human epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) (EPM2A) ELISA kit, Species Human, Sample Type serum, plasma 96T
20-372-60229 epilepsy. progressive myoclonus type 2A. Lafora disease (laforin) (EPM2A). transcript variant 1 - Mouse monoclonal anti-human EPM2A antibody; EC 3.1.3.48; EC 3.1.3.16; Lafora PTPase; LAFPTPase Monoclo 0.1 mg
ECD ECA1 Gene epilepsy, childhood absence 1
25-467 HBP1 is a transcriptional repressor that binds to the promoter region of target genes. This protein plays a role in the regulation of the cell cycle and of the Wnt pathway. It binds preferentially to 0.05 mg
CLNK CLN8 Gene ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation)
30-655 DNTTIP1 binds DNA and enhances the activity of terminal deoxynucleotidyltransferase (TDT, or DNTT), a DNA polymerase that catalyzes the polymerization of DNA in the absence of a DNA template. 0.1 mg
27-114 TCF7L1 participates in the Wnt signaling pathway. It binds to DNA and acts as a repressor in the absence of CTNNB1, and as an activator in its presence. It is necessary for the terminal differentiatio 0.05 mg
25-004 TCF7L1 participates in the Wnt signaling pathway. It binds to DNA and acts as a repressor in the absence of CTNNB1, and as an activator in its presence. It is necessary for the terminal differentiatio 0.05 mg
CSB-EL005569RA Rat ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation) (CLN8) ELISA kit, Species Rat, Sample Type serum, plasma 96T
CSB-EL005569DO Dog ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation) (CLN8) ELISA kit, Species Dog, Sample Type serum, plasma 96T
30-295 NOBOX is a transcription factor which may play a role in oogenesis. It binds preferentially to the DNA sequences 5'-TAATTG-3', 5'-TAGTTG-3' and 5'-TAATTA-3'. 0.05 mg
29-187 NOBOX is a transcription factor which may play a role in oogenesis. It binds preferentially to the DNA sequences 5'-TAATTG-3', 5'-TAGTTG-3' and 5'-TAATTA-3'. 0.05 mg
CSB-EL005569HU Human ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation) (CLN8) ELISA kit, Species Human, Sample Type serum, plasma 96T
CSB-EL005569MO Mouse ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation) (CLN8) ELISA kit, Species Mouse, Sample Type serum, plasma 96T
29-163 POU5F2 is a transcription factor that binds preferentially to the octamer motif (5'-ATGTTAAT-3'). It may exert a regulatory function in meiotic events that are required for terminal differentiation of 0.1 mg
28-462 HMG1L10 contains 2 HMG box DNA-binding domains and belongs to the HMGB family. It binds preferentially single-stranded DNA and unwinds double stranded DNA. 0.1 mg
25-124 PURA is a sequence-specific, single-stranded DNA-binding protein. It binds preferentially to the single strand of the purine-rich element termed PUR, which is present at origins of replication and in 0.05 mg
25-445 PURA is a sequence-specific, single-stranded DNA-binding protein. It binds preferentially to the single strand of the purine-rich element termed PUR, which is present at origins of replication and in 0.05 mg
25-189 RBBP5 contains 6 WD repeats. It binds preferentially to underphosphorylated retinoblastoma protein. The protein encoded by this gene is a ubiquitously expressed nuclear protein and belongs to a highly 0.05 mg


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur